PANews reported on September 29 that Faraday Future founder Jia Yueting wrote that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. This strategic investment is expected to be completed this week, and the encryption flywheel is accelerating.
Earlier on September 20, it was reported that Faraday Future plans to invest US$41 million in Qualigen through PIPE for cryptocurrency business ; Qualigen will be renamed CXC10 and transformed into an encryption and Web3 business platform.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.